Abstract
Zinc transporter 8 (ZnT8) is a major autoantigen and a predictive marker in type 1 diabetes (T1D). To investigate ZnT8-specific antibodies, a phage display library from T1D was constructed and single-chain antibodies against ZnT8 were screened and identified. Human T1D single-chain variable fragment (scFv) phage display library consists of approximately 1×108 clones. After four rounds of bio-panning, seven unique clones were positive by phage ELISA. Among them, C27 and C22, which demonstrated the highest affinity to ZnT8, were expressed in Escherichia coli Top10F’ and then purified by affinity chromatography. C27 and C22 specifically bound ZnT8 N/C fusion protein and ZnT8 C terminal dimer with one Arg325Trp mutation. The specificity to human islet cells of these scFvs were further confirmed by immunohistochemistry. In conclusion, we have successfully constructed a T1D phage display antibody library and identified two ZnT8-specific scFv clones, C27 and C22. These ZnT8-specific scFvs are potential agents in immunodiagnostic and immunotherapy of T1D.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barbas, C.F., Burton, D.R., Scott, J.K., and Silverman, G.J. (2004). Phage display: a laboratory manual (CSHL Press).
Brenner, M.K., and Heslop, H.E. (2010). Adoptive T cell therapy of cancer, Curr Opin Immunol 22, 251–257.
Cheadle, E.J., Gornall, H., Baldan, V., Hanson, V., Hawkins, R.E., and Gilham, D.E. (2014). CAR T cells: driving the road from the laboratory to the clinic, Immunol Rev 257, 91–106.
Chimienti, F., Devergnas, S., Favier, A., and Seve, M. (2004). Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules, Diabetes 53, 2330–2337.
Chimienti, F., Devergnas, S., Pattou, F., Schuit, F., Garcia-Cuenca, R., Vandewalle, B., Kerr-Conte, J., Van Lommel, L., Grunwald, D., Favier, A., and Seve, M. (2006). In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion, J Cell Sci 119, 4199–4206.
Dang, M., Rockell, J., Wagner, R., Wenzlau, J.M., Yu, L., Hutton, J.C., Gottlieb, P.A., and Davidson, H.W. (2011). Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8, J Immunol 186, 6056–6063.
Ehrenmann, F., Kaas, Q., and Lefranc, M.P. (2010). IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF, Nucleic Acids Res 38, D301–307.
Elinav, E., Adam, N., Waks, T., and Eshhar, Z. (2009). Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor, Gastroenterology 136, 1721–1731.
Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., Harris, R.A., Magnusson, P.U., Brittebo, E., and Loskog, A.S. (2012). CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery, J Neuroinflammation 9, 112.
Gu, Y., Zhang, M., Chen, H., Wang, Z., Xing, C., Yang, H., Xu, X., Liu, Y., Zhou, Z., Yu, L., Hutton, J., Eisenbarth, G., and Yang, T. (2011). Discordant association of islet autoantibodies with high-risk HLA genes in Chinese type 1 diabetes, Diabetes Metab Res Rev 27, 899–905.
Hasholzner, U., Stieber, P., Meier, W., and Lamerz, R. (1997). Value of HAMA—determination in clinical practice—an overview, Anticancer Res 17, 3055–3058.
Kawasaki, E. (2012). ZnT8 and type 1 diabetes, Endocr J 59, 531–537.
Kawasaki, E., Tanaka, M., Miwa, M., Abiru, N., and Kawakami, A. (2014). Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies, Acta Diabetol 51, 429–434.
Kawasaki, E., Uga, M., Nakamura, K., Kuriya, G., Satoh, T., Fujishima, K., Ozaki, M., Abiru, N., Yamasaki, H., Wenzlau, J.M., Davidson, H.W., Hutton, J.C., and Eguchi, K. (2008). Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes, Diabetologia 51, 2299–2302.
Kohler, G., and Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256, 495–497.
Lefranc, M.P., Giudicelli, V., Duroux, P., Jabado-Michaloud, J., Folch, G., Aouinti, S., Carillon, E., Duvergey, H., Houles, A., Paysan-Lafosse, T., Hadi-Saljoqi, S., Sasorith, S., Lefranc, G., and Kossida, S. (2015). IMGT(R), the international ImMunoGeneTics information system(R) 25 years on, Nucleic Acids Res 43, D413–422.
MacDonald, K.G., Hoeppli, R.E., Huang, Q., Gillies, J., Luciani, D.S., Orban, P.C., Broady, R., and Levings, M.K. (2016). Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor, J Clin Invest 126, 1413–1424.
McCafferty, J., Griffiths, A.D., Winter, G., and Chiswell, D.J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348, 552–554.
Overbeck, S., Uciechowski, P., Ackland, M.L., Ford, D., and Rink, L. (2008). Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9, J Leukoc Biol 83, 368–380.
Richter, M., and Daquillard, F. (1980). Marked enhancement of antibody synthesis following immunization with antigen bound to host lymphocytes, A potential treatment of patients with allergy. Ann Allergy 44, 152–157.
Seve, M., Chimienti, F., Devergnas, S., and Favier, A. (2004). In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression, BMC Genomics 5, 32.
Skarstrand, H., Krupinska, E., Haataja, T.J., Vaziri-Sani, F., Lagerstedt, J.O., and Lernmark, A. (2015). Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients, Clin Exp Immunol 179, 220–229.
Skarstrand, H., Lernmark, A., and Vaziri-Sani, F. (2013). Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes, Scand J Immunol 77, 21–29.
Ustinova, J., Belitskin, D., Juronen, E., Zusinaite, E., Utt, M., and Uibo, R. (2013). Characterization of monoclonal ZnT8-specific antibody. Front Immunol 02.
Weijers, R.N. (2010). Three-dimensional structure of beta-cell-specific zinc transporter, ZnT-8, predicted from the type 2 diabetes-associated gene variant SLC30A8 R325W, Diabetol Metab Syndr 2, 33.
Wenzlau, J.M., Frisch, L.M., Gardner, T.J., Sarkar, S., Hutton, J.C., and Davidson, H.W. (2009). Novel antigens in type 1 diabetes: the importance of ZnT8, Curr Diab Rep 9, 105–112.
Wenzlau, J.M., Juhl, K., Yu, L., Moua, O., Sarkar, S.A., Gottlieb, P., Rewers, M., Eisenbarth, G.S., Jensen, J., Davidson, H.W., and Hutton, J.C. (2007). The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes, Proc Natl Acad Sci USA 104, 17040–17045.
Wenzlau, J.M., Liu, Y., Yu, L., Moua, O., Fowler, K.T., Rangasamy, S., Walters, J., Eisenbarth, G.S., Davidson, H.W., and Hutton, J.C. (2008). A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes, Diabetes 57, 2693–2697.
Xu, X., Gu, Y., Bian, L., Shi, Y., Cai, Y., Chen, Y., Chen, H., Qian, L., Wu, X., Xu, K., Mallone, R., Davidson, H.W., Yu, L., She, J., Zhang, M., and Yang, T. (2016). Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes, Vaccine 34, 854–862.
Zhang, X., Qi, X., Zhang, Q., Zeng, X., Shi, Z., Jin, Q., Zhan, F., Xu, Y., Liu, Z., Feng, Z., and Jiao, Y. (2013). Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades, Antiviral Res 99, 91–99
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributed equally to this work
This article is published with open access at link.springer.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Wu, Q., Wang, X., Gu, Y. et al. Screening and identification of human ZnT8-specific single-chain variable fragment (scFv) from type 1 diabetes phage display library. Sci. China Life Sci. 59, 686–693 (2016). https://doi.org/10.1007/s11427-016-5077-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-5077-7